Dr. Christopher Wong and Dr. C. Michael Gibson Discuss: DECAF – The Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial November 9, 2025 Disclosures: TBD
Dr. Amrish Deshmukh and Dr. C. Michael Gibson Discuss: META-AF – Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation November 9, 2025 Disclosures: TBD
Dr. Atul Verma and Dr. C. Michael Gibson Discuss: OCEAN – The Need for Ongoing Oral Anticoagulation in Patients with Clinical Stroke Risk Factors After Successful Catheter Ablation of Atrial Fibrillation: The OCEAN Randomized Trial November 8, 2025 Disclosures: TBD
Dr. Jung-Sun Kim and Dr. C. Michael Gibson Discuss: ADAPT AF-DES – Appropriate Duration of Antiplatelet and Thrombotic Strategy after 12 Months in Patients with Atrial Fibrillation Treated with Drug-Eluting Stents November 8, 2025 Disclosures: TBD
Dr. Jeffrey I Weitz and Dr. C. Michael Gibson Discuss: ROXI~ Two Mechanistically Distinct Factor XI Antibodies, REGN9933 and REGN7508, for the Prevention of Venous Thromboembolism After Knee Arthroplasty: the ROXI-VTE-I and ROXI-VTE-II trials November 8, 2025 Disclosures: TBD
Dr. Paul Burton and Dr. C. Michael Gibson Discuss: Effect of Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial November 8, 2025 Disclosures: TBD
Dr. Ruben de Winter and Dr. C. Michael Gibson Discuss: PROCTOR:Native Vessel vs. SVG PCI in Patients With Prior CABG October 28, 2025 Disclosures: TBD
Dr. Matthias Bossard and Dr. C. Michael Gibson Discuss: VICTORY:Intravascular Lithotripsy vs. Super-High-Pressure PTCA in Calcified and Refractory Coronary Lesions October 26, 2025 Disclosures: TBD
Dr. Luke Laffin and I discuss: Efficacy Of Lorundrostat, A Novel Aldosterone Synthase Inhibitor, In Patients With Uncontrolled Hypertension On A Standardized Antihypertensive Medication Regimen March 29, 2025 Disclosures: TBD
